Prähospitaler Einsatz von Blutprodukten

Dietmar Fries; Uwe Hamsen

doi:10.1055/a-2644-7557

NOTARZT
DOI: 10.1055/a-2644-7557

Konsensuspapier

Prähospitaler Einsatz von Blutprodukten

Ein Positionspapier der DIVI-Sektionen „Klinische Hämotherapie und Hämostasemanagement“ und „Trauma“Prehospital Use of Blood ProductsA Position Paper of the DIVI Sections "Clinical Haemotherapy and Haemostasis Management" and "Trauma"

Authors

Dietmar Fries

¹Klinische Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Innsbruck, Innsbruck, Österreich (Ringgold ID: RIN27280)

²DIVI-Sektion “Klinische Hämotherapie und Hämostasemanagement“, Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V.,
Uwe Hamsen

³Klinik für Allgemeine- und Unfallchirurgie, BG-Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Deutschland

⁴DIVI-Sektion “Trauma“, Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V.,

Abstract

Volltext

Referenzen

Literatur
1 Holcomb JB, Donathan DP, Cotton BA. et al. Prehospital Transfusion of Plasma and Red Blood Cells in Trauma Patients. Prehosp Emerg Care 2015; 19: 1-9
2 Rehn M, Weaver A, Brohi K. et al. Effect of Prehospital Red Blood Cell Transfusion on Mortality and Time of Death in Civilian Trauma Patients. Shock 2019; 51: 284-288
3 Shackelford SA, Del Junco DJ, Powell-Dunford N. et al. Association of Prehospital Blood Product Transfusion During Medical Evacuation of Combat Casualties in Afghanistan With Acute and 30-Day Survival. JAMA 2017; 318: 1581-1591
4 Sperry JL, Guyette FX, Brown JB. et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med 2018; 379: 315-326
5 Crombie N, Doughty HA, Bishop JRB. et al. Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol 2022; 9: e250-e261
6 Bundesärztekammer. Richtlinie zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Richtlinie Hämotherapie). Gesamtnovelle 2023. Zugriff am 15. Dezember 2023 unter: https://www.bundesaerztekammer.de/fileadmin/user_upload/BAEK/Themen/Medizin_und_Ethik/Richtlinie-Haemotherapie-2023_neu2.pdf
7 Nitsche E, Dressler J, Henschler R. Systematic Workup of Transfusion Reactions Reveals Passive Co-Reporting of Handling Errors. J Blood Med 2023; 14: 435-443
8 Peters JH, Smulders PSH, Moors XRJ. et al. Are on-scene blood transfusions by a helicopter emergency medical service useful and safe? A multicentre case-control study. Eur J Emerg Med 2019; 26: 128-132
9 Cancelas JA, Nestheide S, Rugg N. et al. Characterization and first-in-human clinical dose-escalation safety evaluation of a next-gen human freeze-dried plasma. Transfusion 2022; 62: 406-417
10 Sheffield WP, Bhakta V, Howell A. et al. Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada. Transfusion 2022; 62: 418-428
11 Rossaint R, Afshari A, Bouillon B. et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care 2023; 27: 80
12 Creel N, Gibson J, Gibson K. et al. Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia. Am Surg 2023; 89: 3794-3798
13 Adams PW, Warren KA, Guyette FX. et al. Implementation of a prehospital air medical thawed plasma program: Is it even feasible?. J Trauma Acute Care Surg 2019; 87: 1077-1081
14 Bodnar D, Rashford S, Williams S. et al. The feasibility of civilian prehospital trauma teams carrying and administering packed red blood cells. Emerg Med J 2014; 31: 93-95
15 Henseler O, Nowak D, Keipert C. Bericht zur Versorgung mit Blut und Blutprodukten 2023: Auswertung der Meldungen zur Gewinnung von Blut, Blutkomponenten und hämatopoetischen Stammzellen sowie zu Herstellung und Verbrauch von Blutprodukten nach § 21 Transfusionsgesetz für das Jahr 2023. 2024 Zugriff am 05. Dezember 2024 unter: https://www.pei.de/21tfg-berichte
16 Mirrione-Savin A, Aghili Pour H, Swarbrick N. et al. Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom. Br J Haematol 2025; 206: 726-734
17 Moore HB, Moore EE, Chapman MP. et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet 2018; 392: 283-291
18 Pusateri AE, Moore EE, Moore HB. et al. Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials. JAMA Surg 2020; 155: e195085
19 Hamed AA, Shuib SM, Elhusein AM. et al. Efficacy and Safety of Prehospital Blood Transfusion in Traumatized Patients: A Systematic Review and Meta-Analysis. Prehosp Disaster Med 2024; 39: 324-334
20 Tucker H, Brohi K, Tan J. et al. Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study. Crit Care 2023; 27: 25
21 Serpa Neto A, Juffermans NP, Hemmes SNT. et al. Interaction between peri-operative blood transfusion, tidal volume, airway pressure and postoperative ARDS: an individual patient data meta-analysis. Ann Transl Med 2018; 6: 23
22 Wang R, Liu R, Xu Z. Association between Plasma Transfusion and in-Hospital Mortality in Critically Ill Patients with Sepsis-Induced Coagulopathy. Shock 2023; 60: 545-552
23 Peng HT, Singh K, Rhind SG. et al. Dried Plasma for Major Trauma: Past, Present, and Future. Life (Basel) 2024; 14: 619
24 DRK-Butspendedienst West. LyoPlas N – w. Gebrauchsinformation und Fachinformation. 2024 Zugriff am 23. April 2025 unter: https://www.blutspendedienst-west.de/transfusionsmedizin/gebrauchs-und-fachinformationen
25 Innerhofer P, Fries D, Mittermayr M. et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 2017; 4: e258-e271
26 Ziegler B, Bachler M, Haberfellner H. et al. Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): A multicentre, double-blind, placebo-controlled, randomised pilot study. Eur J Anaesthesiol 2021; 38: 348-357
27 Bjerkvig CK, Strandenes G, Hervig T. et al. Prehospital Whole Blood Transfusion Programs in Norway. Transfus Med Hemother 2021; 48: 324-331
28 Braverman MA, Smith A, Pokorny D. et al. Prehospital whole blood reduces early mortality in patients with hemorrhagic shock. Transfusion 2021; 61 (Suppl. 1) S15-S21
29 Lier H, Fries D. Emergency Blood Transfusion for Trauma and Perioperative Resuscitation: Standard of Care. Transfus Med Hemother 2021; 48: 366-376
30 Walsh M, Fries D, Moore E. et al. Whole Blood for Civilian Urban Trauma Resuscitation: Historical, Present, and Future Considerations. Semin Thromb Hemost 2020; 46: 221-234
31 Maegele M, Lier H, Hossfeld B. Pre-Hospital Blood Products for the Care of Bleeding Trauma Patients. Dtsch Arztebl Int 2023; 120: 670-676
32 Reifferscheid F. Wissenschaftliche Evaluation zum Einsatz von Blutprodukten im Rettungsdienst – die BAND e. V. richtet Register für prähospitale Hämotherapie ein. NOTARZT 2022; 38: 292